In this issue:
Adaptive changes of the tracheobronchial tree after surgery
Treating cancer-related venous thromboembolism
First-line options for advanced EGFR-mutated NSCLC
Pathway to diagnosis and treatment of NSCLC
ALEX study: Patient-reported outcomes
Gefitinib + chemotherapy for EGFR-mutated lung cancer
Bevacizumab + pemetrexed for non-squamous NSCLC
Nivolumab + ipilimumab for advanced NSCLC
Adjuvant durvalumab for NSCLC
SCLC: Nivolumab ± ipilimumab?
Please login below to download this issue (PDF)